These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35126897)

  • 61. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prostatic Artery Embolization: Equipment, Procedure Steps, and Overcoming Technical Challenges.
    Carnevale FC; de Assis AM; Moreira AM
    Tech Vasc Interv Radiol; 2020 Sep; 23(3):100691. PubMed ID: 33308534
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adenomatous-Dominant Benign Prostatic Hyperplasia (AdBPH) as a Predictor for Clinical Success Following Prostate Artery Embolization: An Age-Matched Case-Control Study.
    Little MW; Boardman P; Macdonald AC; Taylor N; Macpherson R; Crew J; Tapping CR
    Cardiovasc Intervent Radiol; 2017 May; 40(5):682-689. PubMed ID: 28194505
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of three embolic materials at partial splenic artery embolization for hypersplenism: clinical, laboratory, and radiological outcomes.
    Zaitoun MMA; Basha MAA; Elsayed SB; El Deen DS; Zaitoun NA; Alturkistani H; Farag AA; Abdelsalam H; El-Kenawy HA; Mahmoud NEM; Alayouty NA; Eladl IM; Shahin S; Almarzooqi MK; Hendi AM; El-Morsy A; Elmokadem AH
    Insights Imaging; 2021 Jun; 12(1):85. PubMed ID: 34173891
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and Safety of Prostatic Arterial Embolization: Systematic Review with Meta-Analysis and Meta-Regression.
    Shim SR; Kanhai KJ; Ko YM; Kim JH
    J Urol; 2017 Feb; 197(2):465-479. PubMed ID: 27592008
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Retrospective observation of the efficacy and safety of prostatic artery embolization combined with transurethral resection of the prostate and simple transurethral resection of the prostate in the treatment of large (> 100 mL) benign prostatic hyperplasia.
    Tang Y; Wang RL; Ruan DD; Chen X; Zhou YF; Wu SJ; Cai SL; Zhang JH; Yang FG; Luo JW; Fang ZT
    Abdom Radiol (NY); 2021 Dec; 46(12):5746-5757. PubMed ID: 34448024
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia.
    Somwaru AS; Metting S; Flisnik LM; Nellamattathil MG; Sharma A; Katabathina VS
    BMC Urol; 2020 Oct; 20(1):153. PubMed ID: 33032577
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia in the Setting of Bladder Calculi.
    Kim JI; Brader R; Viprakasit DP; Isaacson AJ
    J Vasc Interv Radiol; 2017 Feb; 28(2):306-308. PubMed ID: 28110763
    [No Abstract]   [Full Text] [Related]  

  • 69. Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas.
    Bendszus M; Klein R; Burger R; Warmuth-Metz M; Hofmann E; Solymosi L
    AJNR Am J Neuroradiol; 2000 Feb; 21(2):255-61. PubMed ID: 10696005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Initial Canadian Experience of Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: Midterm Outcomes.
    Patel NR; Elterman DS; Thulasidasan N; Altman R; Tai E; Zener R; Stella SF; Annamalai G; Mafeld S; Simons ME
    Can Assoc Radiol J; 2021 Nov; 72(4):876-882. PubMed ID: 32673069
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy.
    Yu SC; Cho CC; Hung EH; Chiu PK; Yee CH; Ng CF
    Cardiovasc Intervent Radiol; 2017 Jan; 40(1):33-40. PubMed ID: 27853823
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early results and complications of prostatic arterial embolization for benign prostatic hyperplasia.
    Lebdai S; Delongchamps NB; Sapoval M; Robert G; Amouyal G; Thiounn N; Karsenty G; Ruffion A; de La Taille A; Descazeaud A; Mathieu R
    World J Urol; 2016 May; 34(5):625-32. PubMed ID: 26276151
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Unilateral versus bilateral prostatic arterial embolization for lower urinary tract symptoms in patients with prostate enlargement.
    Bilhim T; Pisco J; Rio Tinto H; Fernandes L; Campos Pinheiro L; Duarte M; Pereira JA; Oliveira AG; O'Neill J
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):403-11. PubMed ID: 23232858
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia.
    Pisco JM; Bilhim T; Costa NV; Torres D; Pisco J; Pinheiro LC; Oliveira AG
    Eur Urol; 2020 Mar; 77(3):354-362. PubMed ID: 31831295
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) with Haematuria in the Absence of an Upper Urinary Tract Pathology.
    Tapping CR; Macdonald A; Hadi M; Mortensen C; Crew J; Protheroe A; Little MW; Boardman P
    Cardiovasc Intervent Radiol; 2018 Aug; 41(8):1160-1164. PubMed ID: 29582127
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia.
    Moschouris H; Stamatiou K; Malagari K; Marmaridou K; Kladis-Kalentzis K; Kiltenis M; Papadogeorgopoulos N; Tsavari A; Manoloudaki K
    Diagn Interv Radiol; 2019 Mar; 25(2):134-143. PubMed ID: 30860077
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.
    Zumstein V; Betschart P; Vetterlein MW; Kluth LA; Hechelhammer L; Mordasini L; Engeler DS; Kessler TM; Schmid HP; Abt D
    Eur Urol Focus; 2019 Nov; 5(6):1091-1100. PubMed ID: 30292422
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Superselective prostatic artery embolization in the treatment of large benign prostatic hyperplasia.
    Neymark AI; Karpenko AA; Neymark BA; Tachalov MA; Arzamastsev DD; Torbik DV; Gameeva EV; Bobrov BY; Spivak LG; Korolev DO; Tsarichenko DG; Rapoport LM
    Urologia; 2021 Nov; 88(4):374-381. PubMed ID: 33550913
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study.
    Antunes AA; Carnevale FC; da Motta Leal Filho JM; Yoshinaga EM; Cerri LM; Baroni RH; Marcelino AS; Cerri GG; Srougi M
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):978-86. PubMed ID: 23580116
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nontarget Radiopaque Embolic Deposition during Prostatic Artery Embolization.
    Brown B; Yu H; Bagla S; Isaacson A
    J Vasc Interv Radiol; 2022 May; 33(5):558-563.e1. PubMed ID: 35489786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.